There was no significant difference in the proportion of CD19+ B cells in PBMCs among healthy controls, SLE patients without anti-TRIM21 Ab and SLE patients with anti-TRIM21 Ab (Figure 10A). This evidence concerns the gene TRIM21 and systemic lupus erythematosus.